Clinical and Genetic Epidemiology of Autosomal Dominant Polycystic Kidney Disease among Patients Incident on First Kidney Replacement Therapy between 1990 and 2023, in a Major Hospital in the Northwest of Portugal
Authors:
- Alexandra SilvaASAlexandra Silva
- Pedro Lisboa GonçalvesPGPedro Lisboa Gonçalves
- Liliana CapelaLCLiliana Capela
- Liliana RochaLRLiliana Rocha
- Isabel TavaresITIsabel Tavares
- Susana FernandesSFSusana Fernandes
- João Paulo OliveiraJOJoão Paulo Oliveira
- 7 July 2026
- journal article
- Published by S. Karger AG in Nephron
- p. 1-13
Abstract
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic kidney disease, accounting for 5–10% of incident patients requiring kidney replacement therapy (KRT). Although most cases result from pathogenic variants in PKD1 (≈75%) or PKD2 (≈15%), clinical experience at a major academic hospital in Porto (ULSSJ) suggested a higher regional prevalence of ADPKD-PKD2, particularly involving the truncating variant PKD2 p.(Gln61*). This study aimed to characterize the clinical and genetic epidemiology of ADPKD in patients initiating KRT at ULSSJ, compare ADPKD-PKD1 with ADPKD-PKD2, and contrast local and national ADPKD prevalence among incident KRT patients. Methods: Nephrology reports for KRT initiation (NR-KRT) issued at ULSSJ from 1990 to 2023 were reviewed to identify ADPKD cases and extract demographic and clinical data. Genotypes were obtained from the Genetics Laboratory, Faculty of Medicine, University of Porto, or inferred through pedigree analysis. Next-generation sequencing was the first-tier genotyping test, with Sanger sequencing and multiplex ligation-dependent probe amplification for unresolved cases. National prevalence figures for ADPKD among incident KRT were retrieved from the Portuguese Society of Nephrology registry. Results: Among 6791 NR-KRT reviewed, 426 ADPKD patients were identified. Genotyping information was available for 168 individuals (39.4%), including 101 (60.1%) with inferred genotypes. Among genetically resolved cases, 70.2% had ADPKD-PKD1 and 29.8% had ADPKD-PKD2. Mean age at KRT initiation was 54.5 years in ADPKD-PKD1 and 66.9 years in ADPKD-PKD2. The PKD2 p.(Gln61*) variant was present in 39 patients (23.2%). Between 2010 and 2023, ADPKD prevalence among incident KRT patients was 7.48% at ULSSJ versus 5.19% nationwide (p < 0.0001). Conclusion: The prevalence of ADPKD among incident KRT patients at ULSSJ exceeded national rates. ADPKD-PKD1 was associated with earlier kidney failure compared to ADPKD-PKD2. The PKD2 p.(Gln61*) variant was the most frequent pathogenic allele identified. Given historical patterns of Portuguese emigration, these findings likely have broader international clinical relevance.Keywords
This publication has 48 references indexed in Scilit:
- Cardiovascular Manifestations and Management in ADPKDKidney International Reports, 2023
- Characteristics of Patients with End-Stage Kidney Disease in ADPKDKidney International Reports, 2021
- Detection and characterization of mosaicism in autosomal dominant polycystic kidney diseaseKidney International, 2019
- Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2019
- Autosomal dominant polycystic kidney diseaseThe Lancet, 2019
- Panorámica de la poliquistosis renal autosómica dominante en una región del sur de EspañaNefrología, 2018
- Genetics and Pathogenesis of Autosomal Dominant Polycystic Kidney Disease: 20 Years OnHuman Mutation, 2014
- Autosomal dominant polycystic kidney disease: Comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patientsHuman Mutation, 2012
- Clan Genomics and the Complex Architecture of Human DiseaseCell, 2011
- Homologues to the First Gene for Autosomal Dominant Polycystic Kidney Disease Are PseudogenesGenomics, 2001